持續血糖監測設備市場規模、佔有率及成長分析（按組件、連接性、性別、最終用途和地區）- 產業預測 2025-2032

持續血糖監測設備市場規模預計在 2023 年達到 86.7 億美元，並從 2024 年的 98.4 億美元成長到 2032 年的 271 億美元，預測期內（2025-2032 年）的複合年成長率為 13.5%。

由於糖尿病盛行率不斷上升以及連續血糖監測 (CGM) 設備的普及，糖尿病市場正在經歷顯著成長。國際糖尿病聯盟報告稱，2022 年將有約 5.366 億人被診斷患有糖尿病，並預測到 2030 年這一數字將上升到 6.428 億，到 2045 年將上升到 7.837 億。 CGM 設備不僅提供有關飲食行為、藥物依從性和身體活動的關鍵資料，而且還透過先進的數位治療解決方案改善製造商與患者的關係。許多應用程式正在整合 CGM資料來分析趨勢並建議改變生活方式以改善患者的整體治療效果，從而支持 CGM 設備市場的成長軌跡。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術進步
• 監管格局
• 客戶和購買標準分析
• 專利分析

持續血糖監測設備市場規模（按組件分類）

• 市場概況
• 發送器
• 感應器
• 接收器

持續血糖監測設備市場規模（依連接類型）

• 市場概況
• Bluetooth
• 4G
• 其他

持續血糖監測設備市場規模（依最終用途分類）

• 市場概況
• 醫院
• 居家護理

持續血糖監測設備市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• Dexcom, Inc.（USA）
• Medtronic PLC（Ireland）
• Roche（Switzerland）
• Senseonics Holdings, Inc.（USA）
• GlySens Incorporated（USA）
• Novo Nordisk A/S（Denmark）
• Insulet Corporation（USA）
• Tandem Diabetes Care, Inc.（USA）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• Ypsomed AG（Switzerland）
• Menarini Diagnostics（Italy）
• Nemaura Medical Inc.（UK）
• Medisana GmbH（Germany）
• Sanofi（France）
• Johnson & Johnson（USA）
• Braun Melsungen AG（Germany）
• Arkray, Inc.（Japan）
• Terumo Corporation（Japan）
• MicroTech Medical（China）

結論和建議

Continuous Glucose Monitoring Devices Market size was valued at USD 8.67 billion in 2023 and is poised to grow from USD 9.84 billion in 2024 to USD 27.1 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).

The diabetes market is witnessing significant growth driven by the rising prevalence of the condition and the increasing adoption of continuous glucose monitoring (CGM) devices. The International Diabetes Federation reported that around 536.6 million people were diagnosed with diabetes in 2022, with estimates predicting this figure will rise to 642.8 million by 2030 and 783.7 million by 2045. CGM devices not only provide critical data on dietary behaviors, medication adherence, and physical activity but also foster improved relationships between manufacturers and patients through advanced digital therapeutic solutions. Numerous applications integrate CGM data to analyze trends and recommend lifestyle changes, collectively enhancing patient outcomes and propelling the growth trajectory of the CGM device market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Continuous Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Continuous Glucose Monitoring Devices Market Segments Analysis

Global Continuous Glucose Monitoring Devices Market is segmented by Component, Connectivity, End-use and region. Based on Component, the market is segmented into Transmitters, Sensors and Receivers. Based on Connectivity, the market is segmented into Bluetooth, 4G and Others. Based on End-use, the market is segmented into Hospitals and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Continuous Glucose Monitoring Devices Market

The rising incidence of diabetes worldwide serves as a crucial catalyst for the growth of the Continuous Glucose Monitoring (CGM) Devices market. As the number of individuals managing diabetes continues to climb, there is an urgent need for reliable monitoring and management technologies. Continuous glucose monitoring devices provide real-time feedback, enabling better control of blood sugar levels and improving overall health outcomes for patients. This demand drives innovation and investment in CGM technology, fostering advancements that enhance user experience and accuracy. Consequently, the market for these devices is positioned for substantial growth, addressing the critical needs of an expanding population affected by diabetes.

Restraints in the Continuous Glucose Monitoring Devices Market

Despite advancements in the accuracy of continuous glucose monitoring devices, they can occasionally display discrepancies when compared to traditional blood glucose testing methods. This inconsistency raises concerns among users who rely on precise measurements for managing their health. Such reliability issues can lead to diminished trust in the devices, prompting some individuals to prefer conventional testing approaches. As a result, the perceived accuracy challenges of these innovative tools may become a significant restraint within the market, potentially affecting adoption rates and user satisfaction. Addressing these discrepancies is essential for manufacturers to enhance user confidence and expand market reach.

Market Trends of the Continuous Glucose Monitoring Devices Market

The Continuous Glucose Monitoring (CGM) Devices market is witnessing a significant trend towards integration with digital health platforms, enhancing user experience and data management. This integration allows individuals with diabetes to effortlessly monitor their glucose levels alongside other vital health metrics, facilitating a comprehensive approach to health management. Through mobile applications and cloud-based systems, users can access real-time data, receive personalized insights, and share information with healthcare providers, improving communication and care outcomes. As consumers increasingly seek connected health solutions, this trend is likely to drive growth in the CGM market, fostering innovation and expanding the overall digital health ecosystem.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Patent Analysis

Global Continuous Glucose Monitoring Devices Market Size by Component & CAGR (2025-2032)

• Market Overview
• Transmitters
• Sensors
• Receivers

Global Continuous Glucose Monitoring Devices Market Size by Connectivity & CAGR (2025-2032)

• Market Overview
• Bluetooth
• 4G
• Others

Global Continuous Glucose Monitoring Devices Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Homecare

Global Continuous Glucose Monitoring Devices Market Size & CAGR (2025-2032)

• North America (Component, Connectivity, End-use)
  • US
  • Canada
• Europe (Component, Connectivity, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Connectivity, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Connectivity, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Connectivity, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Senseonics Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlySens Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Diagnostics (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemaura Medical Inc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisana GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTech Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations